Abstract
AbstractProviding the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–pharmacodynamic models in substantially different scenarios with various routes of administration by solving an optimal control problem. The aim is to compute a control that brings the underlying system as closely as possible to a desired reference function by minimizing a cost functional. In pharmacokinetic–pharmacodynamic modeling, the controls are the administered doses and the reference function can be the disease progression. Drug administration at certain time points provides a finite number of discrete controls, the drug doses, determining the drug concentration and its effect on the disease progression. Consequently, rewriting the cost functional gives a finite-dimensional optimal control problem depending only on the doses. Adjoint techniques allow to compute the gradient of the cost functional efficiently. This admits to solve the optimal control problem with robust algorithms such as quasi-Newton methods from finite-dimensional optimization. OptiDose is applied to three relevant but substantially different pharmacokinetic–pharmacodynamic examples.
Funder
Deutsche Forschungsgemeinschaft
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
Springer Science and Business Media LLC
Subject
Applied Mathematics,Management Science and Operations Research,Control and Optimization
Reference33 articles.
1. Van Donge, T., Evers, K., Koch, G., van den Anker, J., Pfister, M.: Clinical Pharmacology and Pharmacometrics to Better Understand Physiological Changes During Pregnancy and Neonatal Life. Handbook of Experimental Pharmacology. Springer, Berlin (2019)
2. Kearns, G.L., Abdel-Rahman, S.M., Alander, S.W., Blowey, D.L., Leeder, J.S., Kauffman, R.E.: Developmental pharmacology—drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 349, 1157–1167 (2003)
3. Koch, G., Datta, D.N., Jost, K., Schulzke, S.M., van den Anker, J., Pfister, M.: Caffeine citrate dosing adjustments to assure stable caffeine concentrations in preterm neonates. J. Pediatr. 191, 50–56 (2017)
4. Gobburu, J.V.S., Marroum, P.J.: Utilisation of pharmacokinetic–pharmacodynamic modeling and simulation in regulatory decision making. Clin. Pharmacokinet 40, 883–892 (2001)
5. Gibaldi, M., Perrier, S.: Pharmacokinetics. CRC Press Tayler & Francis Group, Boca Raton (1982)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献